- Abstract:
-
AIMS: A detailed assessment of ophthalmic effects of an HMG CoA reductase inhibitor, simvastatin, was performed. METHODS: Six hundred and twenty one individuals considered to be at increased risk of coronary heart disease were randomised, following an 8 week placebo 'run in' period, to receive 40 mg daily simvastatin, 20 mg daily simvastatin, or matching placebo. Patients with a baseline corrected visual acuity better than 6/24 and without a history of cataract were eligible for detailed opht...
Expand abstract - Publication status:
- Published
- Journal:
- The British journal of ophthalmology
- Volume:
- 79
- Issue:
- 11
- Pages:
- 996-1002
- Publication date:
- 1995-11-05
- DOI:
- EISSN:
-
1468-2079
- ISSN:
-
0007-1161
- URN:
-
uuid:149eab64-57e2-4510-8db7-4cbe685199fa
- Source identifiers:
-
49375
- Local pid:
- pubs:49375
- Copyright date:
- 1995
Journal article
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record